Previous close | 36.89 |
Open | 36.69 |
Bid | 35.78 x 800 |
Ask | 36.39 x 1100 |
Day's range | 35.72 - 36.69 |
52-week range | 31.01 - 53.80 |
Volume | |
Avg. volume | 5,150,771 |
Market cap | 18.162B |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | 77.83 |
EPS (TTM) | 0.46 |
Earnings date | 07 Feb 2024 - 12 Feb 2024 |
Forward dividend & yield | 1.16 (3.14%) |
Ex-dividend date | 30 Nov 2023 |
1y target est | 43.38 |
79 patients enrolled TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update for the month of November on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. 79 patients enrolled to date an
DEERFIELD, Ill. & NEW YORK, November 28, 2023--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt. Supported by a $2.5 million grant from the Foundation, this three-year initiative aims to implement climate-smart water, sanitation and hygiene (WASH) programming for thousands of people in Upper Egypt’s governor
It looks like Baxter International Inc. ( NYSE:BAX ) is about to go ex-dividend in the next 3 days. Typically, the...